In: Nursing
A 32-year-old female patient was diagnosed with sickle cell anemia had complicated recurrent hospital admissions with vaso-occlusive crises and chest syndrome. Lab findings showed normochromic, normocytic mild to moderate anemia. Genetic investigations showed lysine was substituted for glutamine acid at position 6 on some chains and valine instead of glutamine at position 6 on other chains. What anemia does she have and what are the two genetic (base to base changes) point mutations that cause her disease?
Hbs is the predominant form of haemoglobin in sickle cell patient which has a mutation in the beta chain where a glumatic acid residue is substituted for a valine ( hydrophobic) at position 6 of the beta - chain ( non conservative substitution). Homozygous expression of Hbs produces sickle cell disease (50% sickle cells) where the sickled cells are more fragile and have shorter half lives causing chronic hemolytic anemia as well as a Vasco occlusive condition (may be fatal). Also these sickle/ crescent shaped cell get trapped in small blood vessels leading to tissue damage causing various condition leading to a reduced life span.
Although the haploid human genome consists of 3 billion nucleotides, changes in even a single base can result in dramatic physiological malfunction.for eg, sickle cell anemia is a disease caused by the smallest of genetic changes.here the alterations of single nucleotide in the gene for the beta chain of the haemoglobin protein ( the oxygen carrying protein that makes blood red) is all it takes to turn a normal haemoglobin gene into sickle cell haemoglobin gene.this single nucleotide change alters only one amino acid in the protein chain but the result are devastating.